CINXE.COM

<!DOCTYPE html> <html lang="en" dir="ltr"> <head>  <script async src="https://www.googletagmanager.com/gtag/js?id=G-P63WKM1TM1"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-P63WKM1TM1'); </script>  <script type="text/javascript" > (function(m,e,t,r,i,k,a){m[i]=m[i]||function(){(m[i].a=m[i].a||[]).push(arguments)}; m[i].l=1*new Date(); for (var j = 0; j < document.scripts.length; j++) {if (document.scripts[j].src === r) { return; }} k=e.createElement(t),a=e.getElementsByTagName(t)[0],k.async=1,k.src=r,a.parentNode.insertBefore(k,a)}) (window, document, "script", "https://mc.yandex.ru/metrika/tag.js", "ym"); ym(55165297, "init", { clickmap:false, trackLinks:true, accurateTrackBounce:true, webvisor:false }); </script> <noscript><div><img src="https://mc.yandex.ru/watch/55165297" style="position:absolute; left:-9999px;" alt="" /></div></noscript>    <title>Search results for: pharmaceutical applications</title> <meta name="description" content="Search results for: pharmaceutical applications"> <meta name="keywords" content="pharmaceutical applications"> <meta name="viewport" content="width=device-width, initial-scale=1, minimum-scale=1, maximum-scale=1, user-scalable=no"> <meta charset="utf-8"> <link href="https://cdn.waset.org/favicon.ico" type="image/x-icon" rel="shortcut icon"> <link href="https://cdn.waset.org/static/plugins/bootstrap-4.2.1/css/bootstrap.min.css" rel="stylesheet"> <link href="https://cdn.waset.org/static/plugins/fontawesome/css/all.min.css" rel="stylesheet"> <link href="https://cdn.waset.org/static/css/site.css?v=150220211555" rel="stylesheet"> </head> <body> <header> <div class="container"> <nav class="navbar navbar-expand-lg navbar-light"> <a class="navbar-brand" href="https://waset.org"> <img src="https://cdn.waset.org/static/images/wasetc.png" alt="Open Science Research Excellence" title="Open Science Research Excellence" /> </a> <button class="d-block d-lg-none navbar-toggler ml-auto" type="button" data-toggle="collapse" data-target="#navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"> <span class="navbar-toggler-icon"></span> </button> <div class="w-100"> <div class="d-none d-lg-flex flex-row-reverse"> <form method="get" action="https://waset.org/search" class="form-inline my-2 my-lg-0"> <input class="form-control mr-sm-2" type="search" placeholder="Search Conferences" value="pharmaceutical applications" name="q" aria-label="Search"> <button class="btn btn-light my-2 my-sm-0" type="submit"><i class="fas fa-search"></i></button> </form> </div> <div class="collapse navbar-collapse mt-1" id="navbarMenu"> <ul class="navbar-nav ml-auto align-items-center" id="mainNavMenu"> <li class="nav-item"> <a class="nav-link" href="https://waset.org/conferences" title="Conferences in 2024/2025/2026">Conferences</a> </li> <li class="nav-item"> <a class="nav-link" href="https://waset.org/disciplines" title="Disciplines">Disciplines</a> </li> <li class="nav-item"> <a class="nav-link" href="https://waset.org/committees" rel="nofollow">Committees</a> </li> <li class="nav-item dropdown"> <a class="nav-link dropdown-toggle" href="#" id="navbarDropdownPublications" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false"> Publications </a> <div class="dropdown-menu" aria-labelledby="navbarDropdownPublications"> <a class="dropdown-item" href="https://publications.waset.org/abstracts">Abstracts</a> <a class="dropdown-item" href="https://publications.waset.org">Periodicals</a> <a class="dropdown-item" href="https://publications.waset.org/archive">Archive</a> </div> </li> <li class="nav-item"> <a class="nav-link" href="https://waset.org/page/support" title="Support">Support</a> </li> </ul> </div> </div> </nav> </div> </header> <main> <div class="container mt-4"> <div class="row"> <div class="col-md-9 mx-auto"> <form method="get" action="https://publications.waset.org/abstracts/search"> <div id="custom-search-input"> <div class="input-group"> <i class="fas fa-search"></i> <input type="text" class="search-query" name="q" placeholder="Author, Title, Abstract, Keywords" value="pharmaceutical applications"> <input type="submit" class="btn_search" value="Search"> </div> </div> </form> </div> </div> <div class="row mt-3"> <div class="col-sm-3"> <div class="card"> <div class="card-body"><strong>Commenced</strong> in January 2007</div> </div> </div> <div class="col-sm-3"> <div class="card"> <div class="card-body"><strong>Frequency:</strong> Monthly</div> </div> </div> <div class="col-sm-3"> <div class="card"> <div class="card-body"><strong>Edition:</strong> International</div> </div> </div> <div class="col-sm-3"> <div class="card"> <div class="card-body"><strong>Paper Count:</strong> 6917</div> </div> </div> </div> <h1 class="mt-3 mb-3 text-center" style="font-size:1.6rem;">Search results for: pharmaceutical applications</h1> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6917</span> IP Management Tools, Strategies, Best Practices, and Business Models for Pharmaceutical Products</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Nerella%20Srinivas">Nerella Srinivas</a> </p> <p class="card-text"><strong>Abstract:</strong></p> This study investigates the role of intellectual property (IP) management in pharmaceutical development, focusing on tools, strategies, and business models for leveraging IP effectively. Using a mixed-methods approach, we conducted case studies and qualitative analyses of IP management frameworks within the pharmaceutical sector. Our methodology included a review of IP tools tailored for pharmaceutical applications, strategic IP models for maximizing competitive advantages, and best practices for organizational efficiency. Findings emphasize the importance of understanding IP law and adopting adaptive strategies, illustrating how IP management can drive industry growth. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=intellectual%20property%20management" title="intellectual property management">intellectual property management</a>, <a href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20products" title=" pharmaceutical products"> pharmaceutical products</a>, <a href="https://publications.waset.org/abstracts/search?q=IP%20tools" title=" IP tools"> IP tools</a>, <a href="https://publications.waset.org/abstracts/search?q=IP%20strategies" title=" IP strategies"> IP strategies</a>, <a href="https://publications.waset.org/abstracts/search?q=best%20practices" title=" best practices"> best practices</a>, <a href="https://publications.waset.org/abstracts/search?q=business%20models" title=" business models"> business models</a>, <a href="https://publications.waset.org/abstracts/search?q=innovation" title=" innovation"> innovation</a> </p> <a href="https://publications.waset.org/abstracts/193084/ip-management-tools-strategies-best-practices-and-business-models-for-pharmaceutical-products" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/193084.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">13</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6916</span> Pharmaceutical Applications of Newton's Second Law and Disc Inertia</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Nicholas%20Jensen">Nicholas Jensen</a> </p> <p class="card-text"><strong>Abstract:</strong></p> As the effort to create new drugs to treat rare conditions cost-effectively intensifies, there is a need to ensure maximum efficiency in the manufacturing process. This includes the creation of ultracompact treatment forms, which can best be achieved via applications of fundamental laws of physics. This paper reports an experiment exploring the relationship between the forms of Newton's 2ⁿᵈ Law appropriate to linear motion and to transversal architraves. The moment of inertia of three discs was determined by experiments and compared with previous data derived from a theoretical relationship. The method used was to attach the discs to a moment arm. Comparing the results with those obtained from previous experiments, it is found to be consistent with the first law of thermodynamics. It was further found that Newton's 2ⁿᵈ law violates the second law of thermodynamics. The purpose of this experiment was to explore the relationship between the forms of Newton's 2nd Law appropriate to linear motion and to apply torque to a twisting force, which is determined by position vector r and force vector F. Substituting equation alpha in place of beta; angular acceleration is a linear acceleration divided by radius r of the moment arm. The nevrological analogy of Newton's 2nd Law states that these findings can contribute to a fuller understanding of thermodynamics in relation to viscosity. Implications for the pharmaceutical industry will be seen to be fruitful from these findings. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=Newtonian%20physics" title="Newtonian physics">Newtonian physics</a>, <a href="https://publications.waset.org/abstracts/search?q=inertia" title=" inertia"> inertia</a>, <a href="https://publications.waset.org/abstracts/search?q=viscosity" title=" viscosity"> viscosity</a>, <a href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20applications" title=" pharmaceutical applications"> pharmaceutical applications</a> </p> <a href="https://publications.waset.org/abstracts/126921/pharmaceutical-applications-of-newtons-second-law-and-disc-inertia" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/126921.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">117</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6915</span> Patent Protection for AI Innovations in Pharmaceutical Products</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Nerella%20Srinivas">Nerella Srinivas</a> </p> <p class="card-text"><strong>Abstract:</strong></p> This study explores the significance of patent protection for artificial intelligence (AI) innovations in the pharmaceutical sector, emphasizing applications in drug discovery, personalized medicine, and clinical trial optimization. The challenges of patenting AI-driven inventions are outlined, focusing on the classification of algorithms as abstract ideas, meeting the non-obviousness standard, and issues around defining inventorship. The methodology includes examining case studies and existing patents, with an emphasis on how companies like Benevolent AI and Insilico Medicine have successfully secured patent rights. Findings demonstrate that a strategic approach to patent protection is essential, with particular attention to showcasing AI’s technical contributions to pharmaceutical advancements. Conclusively, the study underscores the critical role of understanding patent law and innovation strategies in leveraging intellectual property rights in the rapidly advancing field of AI-driven pharmaceuticals. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=artificial%20intelligence" title="artificial intelligence">artificial intelligence</a>, <a href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20industry" title=" pharmaceutical industry"> pharmaceutical industry</a>, <a href="https://publications.waset.org/abstracts/search?q=patent%20protection" title=" patent protection"> patent protection</a>, <a href="https://publications.waset.org/abstracts/search?q=drug%20discovery" title=" drug discovery"> drug discovery</a>, <a href="https://publications.waset.org/abstracts/search?q=personalized%20medicine" title=" personalized medicine"> personalized medicine</a>, <a href="https://publications.waset.org/abstracts/search?q=clinical%20trials" title=" clinical trials"> clinical trials</a>, <a href="https://publications.waset.org/abstracts/search?q=intellectual%20property" title=" intellectual property"> intellectual property</a>, <a href="https://publications.waset.org/abstracts/search?q=non-obviousness" title=" non-obviousness"> non-obviousness</a> </p> <a href="https://publications.waset.org/abstracts/193083/patent-protection-for-ai-innovations-in-pharmaceutical-products" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/193083.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">12</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6914</span> Fiqh Challenge in Production of Halal Pharmaceutical Products</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Saadan%20Man">Saadan Man</a>, <a href="https://publications.waset.org/abstracts/search?q=Razidah%20Othmanjaludin"> Razidah Othmanjaludin</a>, <a href="https://publications.waset.org/abstracts/search?q=Madiha%20Baharuddin"> Madiha Baharuddin</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Nowadays, the pharmaceutical products are produced through the mixing of active and complex ingredient, naturally or synthetically; and involve extensive use of prohibited animal products. This article studies the challenges faced from fiqh perspective in the production of halal pharmaceutical products which frequently contain impure elements or prohibited animal derivatives according to Islamic law. This study is qualitative which adopts library research as well as field research by conducting series of interviews with the several related parties. The gathered data is analyzed from Sharia perspective by using some instruments especially the principle of Maqasid of Sharia. This study shows that the halal status of pharmaceutical products depends on the three basic elements: the sources of the basic ingredient; the processes involved in three phases of production, i.e., before, during and after; and the possible effects of the products. Various fiqh challenges need to be traversed in producing halal pharmaceutical products including the sources of the ingredients, the logistic process, the tools used, and the procedures of productions. Thus, the whole supply chain of production of pharmaceutical products must be well managed in accordance to the halal standard. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=fiqh" title="fiqh">fiqh</a>, <a href="https://publications.waset.org/abstracts/search?q=halal%20pharmaceutical" title=" halal pharmaceutical"> halal pharmaceutical</a>, <a href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20products" title=" pharmaceutical products"> pharmaceutical products</a>, <a href="https://publications.waset.org/abstracts/search?q=Malaysia" title=" Malaysia"> Malaysia</a> </p> <a href="https://publications.waset.org/abstracts/97564/fiqh-challenge-in-production-of-halal-pharmaceutical-products" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/97564.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">192</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6913</span> The Application of Enzymes on Pharmaceutical Products and Process Development</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Reginald%20%20Anyanwu">Reginald Anyanwu</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Enzymes are biological molecules that significantly regulate the rate of almost all of the chemical reactions that take place within cells, and have been widely used for products’ innovations. They are vital for life and serve a wide range of important functions in the body, such as aiding in digestion and metabolism. The present study was aimed at finding out the extent to which biological molecules have been utilized by pharmaceutical, food and beverage, and biofuel industries in commercial and scale up applications. Taking into account the escalating business opportunities in this vertical, biotech firms have also been penetrating enzymes industry especially that of food. The aim of the study therefore was to find out how biocatalysis can be successfully deployed; how enzyme application can improve industrial processes. To achieve the purpose of the study, the researcher focused on the analytical tools that are critical for the scale up implementation of enzyme immobilization to ascertain the extent of increased product yield at minimum logistical burden and maximum market profitability on the environment and user. The researcher collected data from four pharmaceutical companies located at Anambra state and Imo state of Nigeria. Questionnaire items were distributed to these companies. The researcher equally made a personal observation on the applicability of these biological molecules on innovative Products since there is now shifting trends toward the consumption of healthy and quality food. In conclusion, it was discovered that enzymes have been widely used for products’ innovations but there are however variations on their applications. It was also found out that pivotal contenders of enzymes market have lately been making heavy investments in the development of innovative product solutions. It was recommended that the applications of enzymes on innovative products should be widely practiced. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=enzymes" title="enzymes">enzymes</a>, <a href="https://publications.waset.org/abstracts/search?q=pharmaceuticals" title=" pharmaceuticals"> pharmaceuticals</a>, <a href="https://publications.waset.org/abstracts/search?q=process%20development" title=" process development"> process development</a>, <a href="https://publications.waset.org/abstracts/search?q=quality%20food%20consumption" title=" quality food consumption"> quality food consumption</a>, <a href="https://publications.waset.org/abstracts/search?q=scale-up%20applications" title=" scale-up applications"> scale-up applications</a> </p> <a href="https://publications.waset.org/abstracts/126613/the-application-of-enzymes-on-pharmaceutical-products-and-process-development" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/126613.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">139</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6912</span> A Critical Review of the Success Model of Indian Pharmaceutical Industry</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Ekta%20Pandey">Ekta Pandey</a> </p> <p class="card-text"><strong>Abstract:</strong></p> The Indian Pharmaceutical Industry is ranked third largest by volume and fourteenth by value. It thus accounts for 10% of world’s production by volume and 1.5% by value according to Department of Pharmaceuticals, Government of India. The industry has shown phenomenal growth over past few years, moving from US $ 1 billion turnover in 1990 to a turnover of around US $30 billion in 2015. The Indian pharmaceutical sector is ranked seventeenth in terms of export value of active pharmaceutical ingredients and dosage forms to more than 200 countries around the globe. It has shown tremendous changes especially after Trade Related Aspects of Intellectual Property Rights (TRIPS) agreement. Recognizing the immense potential for growth and its direct impact on Indian economy, it is important to look up the industrial policies adopted since Indian independence which turnaround the Indian pharmaceutical industry. A systematic review of changes in market structure of Indian pharmaceutical industry due to shift in policy regimes is done from 1850 to 2015 using secondary peer reviewed published research work. The aim is to understand the impact of anti-trust laws, intellectual property rights, industry competition acts and regulations are quite crucial in determining effective economic policy and have overall lasting effects on international trade and ties. The proposed paper examines the position of Indian domestic firms relative to multinational pharmaceutical firms tries to throw some light on the growth curve of Indian pharmaceutical sector. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=active%20pharmaceutical%20ingredients" title="active pharmaceutical ingredients">active pharmaceutical ingredients</a>, <a href="https://publications.waset.org/abstracts/search?q=competition%20act" title=" competition act"> competition act</a>, <a href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20industry" title=" pharmaceutical industry"> pharmaceutical industry</a>, <a href="https://publications.waset.org/abstracts/search?q=TRIPS" title=" TRIPS"> TRIPS</a> </p> <a href="https://publications.waset.org/abstracts/76944/a-critical-review-of-the-success-model-of-indian-pharmaceutical-industry" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/76944.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">438</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6911</span> The Bloom of 3D Printing in the Health Care Industry</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Mihika%20Shivkumar">Mihika Shivkumar</a>, <a href="https://publications.waset.org/abstracts/search?q=Krishna%20Kumar"> Krishna Kumar</a>, <a href="https://publications.waset.org/abstracts/search?q=C.%20Perisamy"> C. Perisamy</a> </p> <p class="card-text"><strong>Abstract:</strong></p> 3D printing is a method of manufacturing wherein materials, such as plastic or metal, are deposited in layers one on top of the other to produce a three dimensional object. 3D printing is most commonly associated with creating engineering prototypes. However, its applications in the field of human health care have been frequently disregarded. Medical applications for 3D printing are expanding rapidly and are envisaged to revolutionize health care. Medical applications for 3D printing, both present and its potential, can be categorized broadly, including: creation of customized prosthetics tissue and organ fabrication; creation of implants, and anatomical models and pharmaceutical research regarding drug dosage forms. This piece breaks down bioprinting in the healthcare sector. It focuses on the better subtle elements of every particular point, including how 3D printing functions in the present, its impediments, and future applications in the health care sector. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=bio-printing" title="bio-printing">bio-printing</a>, <a href="https://publications.waset.org/abstracts/search?q=prototype" title=" prototype"> prototype</a>, <a href="https://publications.waset.org/abstracts/search?q=drug%20delivery" title=" drug delivery"> drug delivery</a>, <a href="https://publications.waset.org/abstracts/search?q=organ%20regeneration" title=" organ regeneration"> organ regeneration</a> </p> <a href="https://publications.waset.org/abstracts/44541/the-bloom-of-3d-printing-in-the-health-care-industry" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/44541.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">271</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6910</span> An Analysis of Present Supplier Selection Criteria of State Pharmaceutical Corporation (SPC) Sri Lanka: A Case Study</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Gamalath%20M.%20B.%20P.%20Abeysekara">Gamalath M. B. P. Abeysekara</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Primary objective of any organization is to enhance the bottom line profit. Strategic procurement is one of the prominent aspects in view of receiving this ultimate objective. Strategic procurement is an activity used in each and every organization in their operations. Pharmaceutical procurement is an especially significant task for any organizations, particularly state sector concerned. The whole pharmaceutical procurement requirement of the country is procured through the State Pharmaceutical Corporation (SPC) of Sri Lanka. They follow Pharmaceutical Procurement Guideline of 2006 as the procurement principle. The main objective of this project is to identify the importance of State Pharmaceutical Corporation supplier selection criteria and critical analysis of pharmaceutical procurement procedure. State Pharmaceutical Corporations applied net price, product quality, past performance, and delivery of suppliers’ as main criteria for the selection suppliers. Data collection for this study was taken place through a questionnaire, given to fifty doctors within the Colombo district attached to five main state hospitals. Data analysis is carried out with mean and standard deviation functions. The ultimate outcomes indicated product quality, net price, and delivery of suppliers’ are the most important criteria behind the selection of suppliers. Critical analysis proved State Pharmaceutical Corporation should focus on net price reduction, improving laboratory testing facilities and effective communication between up and down stream of supply chain. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=government%20procurement%20procedure" title="government procurement procedure">government procurement procedure</a>, <a href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20procurement%20supplier%20selection%20criteria" title=" pharmaceutical procurement supplier selection criteria"> pharmaceutical procurement supplier selection criteria</a>, <a href="https://publications.waset.org/abstracts/search?q=importance%20of%20SPC%20supplier%20selection%20criteria" title=" importance of SPC supplier selection criteria "> importance of SPC supplier selection criteria </a> </p> <a href="https://publications.waset.org/abstracts/23053/an-analysis-of-present-supplier-selection-criteria-of-state-pharmaceutical-corporation-spc-sri-lanka-a-case-study" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/23053.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">451</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6909</span> Pharmaceutical Science and Development in Drug Research</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Adegoke%20Yinka%20Adebayo">Adegoke Yinka Adebayo </a> </p> <p class="card-text"><strong>Abstract:</strong></p> An understanding of the critical product attributes that impact on in vivo performance is key to the production of safe and effective medicines. Thus, a key driver for our research is the development of new basic science and technology underpinning the development of new pharmaceutical products. Research includes the structure and properties of drugs and excipients, biopharmaceutical characterisation, pharmaceutical processing and technology and formulation and analysis. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=drug%20discovery" title="drug discovery">drug discovery</a>, <a href="https://publications.waset.org/abstracts/search?q=drug%20development" title=" drug development"> drug development</a>, <a href="https://publications.waset.org/abstracts/search?q=drug%20delivery" title=" drug delivery "> drug delivery </a> </p> <a href="https://publications.waset.org/abstracts/19017/pharmaceutical-science-and-development-in-drug-research" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/19017.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">494</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6908</span> Detection of Pharmaceutical Personal Protective Equipment in Video Stream</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Michael%20Leontiev">Michael Leontiev</a>, <a href="https://publications.waset.org/abstracts/search?q=Danil%20Zhilikov"> Danil Zhilikov</a>, <a href="https://publications.waset.org/abstracts/search?q=Dmitry%20Lobanov"> Dmitry Lobanov</a>, <a href="https://publications.waset.org/abstracts/search?q=Lenar%20Klimov"> Lenar Klimov</a>, <a href="https://publications.waset.org/abstracts/search?q=Vyacheslav%20Chertan"> Vyacheslav Chertan</a>, <a href="https://publications.waset.org/abstracts/search?q=Daniel%20Bobrov"> Daniel Bobrov</a>, <a href="https://publications.waset.org/abstracts/search?q=Vladislav%20Maslov"> Vladislav Maslov</a>, <a href="https://publications.waset.org/abstracts/search?q=Vasilii%20Vologdin"> Vasilii Vologdin</a>, <a href="https://publications.waset.org/abstracts/search?q=Ksenia%20Balabaeva"> Ksenia Balabaeva</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Pharmaceutical manufacturing is a complex process, where each stage requires a high level of safety and sterility. Personal Protective Equipment (PPE) is used for this purpose. Despite all the measures of control, the human factor (improper PPE wearing) causes numerous losses to human health and material property. This research proposes a solid computer vision system for ensuring safety in pharmaceutical laboratories. For this, we have tested a wide range of state-of-the-art object detection methods. Composing previously obtained results in this sphere with our own approach to this problem, we have reached a high accuracy (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="e78aa6b7a7d7c9d2">[email protected]</a>) ranging from 0.77 up to 0.98 in detecting all the elements of a common set of PPE used in pharmaceutical laboratories. Our system is a step towards safe medicine production. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=sterility%20and%20safety%20in%20pharmaceutical%20development" title="sterility and safety in pharmaceutical development">sterility and safety in pharmaceutical development</a>, <a href="https://publications.waset.org/abstracts/search?q=personal%20protective%20equipment" title=" personal protective equipment"> personal protective equipment</a>, <a href="https://publications.waset.org/abstracts/search?q=computer%20vision" title=" computer vision"> computer vision</a>, <a href="https://publications.waset.org/abstracts/search?q=object%20detection" title=" object detection"> object detection</a>, <a href="https://publications.waset.org/abstracts/search?q=monitoring%20in%20pharmaceutical%20development" title=" monitoring in pharmaceutical development"> monitoring in pharmaceutical development</a>, <a href="https://publications.waset.org/abstracts/search?q=PPE" title=" PPE"> PPE</a> </p> <a href="https://publications.waset.org/abstracts/176685/detection-of-pharmaceutical-personal-protective-equipment-in-video-stream" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/176685.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">87</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6907</span> Counterfeit Drugs Prevention in Pharmaceutical Industry with RFID: A Framework Based On Literature Review</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Zeeshan%20Hamid">Zeeshan Hamid</a>, <a href="https://publications.waset.org/abstracts/search?q=Asher%20Ramish"> Asher Ramish</a> </p> <p class="card-text"><strong>Abstract:</strong></p> The purpose of this paper is to focus on security and safety issues facing by pharmaceutical industry globally when counterfeit drugs are in question. Hence, there is an intense need to secure and authenticate pharmaceutical products in the emerging counterfeit product market. This paper will elaborate the application of radio frequency identification (RFID) in pharmaceutical industry and to identify its key benefits for patient’s care. The benefits are: help to co-ordinate the stream of supplies, accuracy in chains of supplies, maintaining trustworthy information, to manage the operations in appropriate and timely manners and finally deliver the genuine drug to patient. It is discussed that how RFID supported supply chain information sharing (SCIS) helps to combat against counterfeit drugs. And a solution how to tag pharmaceutical products; since, some products prevent RFID implementation in this industry. In this paper, a proposed model for pharma industry distribution suggested to combat against the counterfeit drugs when they are in supply chain. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=supply%20chain" title="supply chain">supply chain</a>, <a href="https://publications.waset.org/abstracts/search?q=RFID" title=" RFID"> RFID</a>, <a href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20industry" title=" pharmaceutical industry"> pharmaceutical industry</a>, <a href="https://publications.waset.org/abstracts/search?q=counterfeit%20drugs" title=" counterfeit drugs"> counterfeit drugs</a>, <a href="https://publications.waset.org/abstracts/search?q=patients%20care" title=" patients care"> patients care</a> </p> <a href="https://publications.waset.org/abstracts/5370/counterfeit-drugs-prevention-in-pharmaceutical-industry-with-rfid-a-framework-based-on-literature-review" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/5370.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">313</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6906</span> Spectroscopy Study of Jatropha curcas Seed Oil for Pharmaceutical Applications</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Bashar%20Mudhaffar%20Abdullah">Bashar Mudhaffar Abdullah</a>, <a href="https://publications.waset.org/abstracts/search?q=Hasniza%20Zaman%20Huri"> Hasniza Zaman Huri</a>, <a href="https://publications.waset.org/abstracts/search?q=Nany%20Hairunisa"> Nany Hairunisa</a> </p> <p class="card-text"><strong>Abstract:</strong></p> This study was carried out to determine the thermal properties and spectroscopy study of Malaysian Jatropha curcas seed oil. The J. curcas seed oil physicochemical properties such as free fatty acid (FFA %), acid value, saponification value, iodine value, unsaponifiable matter, and viscosity (cp) gave values of 1.89±0.10%, 3.76±0.07, 203.36±0.36 mg/g, 4.90±0.25, 1.76±0.03%, and 32, respectively. Gas chromatography (GC) was used to determine the fatty acids (FAs) composition. J. curcas seed oil is consisting of saturated FAs (19.55%) such as palmitic (13.19%), palmitoleic (0.40%), and stearic (6.36%) acids and unsaturated FAs (80.42%) such as oleic (43.32%) and linoleic (36.70%) acids. The thermal properties using differential scanning calorimetry (DSC) showed that crystallized TAG was observed at -6.79°C. The melting curves displayed three major exothermic regions of J. curcas seed oil, monounsaturated (lower-temperature peak) at -31.69°C, di-unsaturated (medium temperature peak) at -20.23°C and tri-unsaturated (higher temperature peak) at -12.72°C. The results of this study showed that the J. curcas seed oil is a plausible source of polyunsaturated fatty acid (PUFA) to be developed in the future for pharmaceutical applications. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=Jatropha%20curcas%20seed%20oil" title="Jatropha curcas seed oil">Jatropha curcas seed oil</a>, <a href="https://publications.waset.org/abstracts/search?q=thermal%20properties" title=" thermal properties"> thermal properties</a>, <a href="https://publications.waset.org/abstracts/search?q=crystallization" title=" crystallization"> crystallization</a>, <a href="https://publications.waset.org/abstracts/search?q=melting" title=" melting"> melting</a>, <a href="https://publications.waset.org/abstracts/search?q=spectroscopy" title=" spectroscopy"> spectroscopy</a> </p> <a href="https://publications.waset.org/abstracts/18315/spectroscopy-study-of-jatropha-curcas-seed-oil-for-pharmaceutical-applications" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/18315.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">478</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6905</span> An Enhanced Approach in Validating Analytical Methods Using Tolerance-Based Design of Experiments (DoE)</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Gule%20Teri">Gule Teri</a> </p> <p class="card-text"><strong>Abstract:</strong></p> The effective validation of analytical methods forms a crucial component of pharmaceutical manufacturing. However, traditional validation techniques can occasionally fail to fully account for inherent variations within datasets, which may result in inconsistent outcomes. This deficiency in validation accuracy is particularly noticeable when quantifying low concentrations of active pharmaceutical ingredients (APIs), excipients, or impurities, introducing a risk to the reliability of the results and, subsequently, the safety and effectiveness of the pharmaceutical products. In response to this challenge, we introduce an enhanced, tolerance-based Design of Experiments (DoE) approach for the validation of analytical methods. This approach distinctly measures variability with reference to tolerance or design margins, enhancing the precision and trustworthiness of the results. This method provides a systematic, statistically grounded validation technique that improves the truthfulness of results. It offers an essential tool for industry professionals aiming to guarantee the accuracy of their measurements, particularly for low-concentration components. By incorporating this innovative method, pharmaceutical manufacturers can substantially advance their validation processes, subsequently improving the overall quality and safety of their products. This paper delves deeper into the development, application, and advantages of this tolerance-based DoE approach and demonstrates its effectiveness using High-Performance Liquid Chromatography (HPLC) data for verification. This paper also discusses the potential implications and future applications of this method in enhancing pharmaceutical manufacturing practices and outcomes. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=tolerance-based%20design" title="tolerance-based design">tolerance-based design</a>, <a href="https://publications.waset.org/abstracts/search?q=design%20of%20experiments" title=" design of experiments"> design of experiments</a>, <a href="https://publications.waset.org/abstracts/search?q=analytical%20method%20validation" title=" analytical method validation"> analytical method validation</a>, <a href="https://publications.waset.org/abstracts/search?q=quality%20control" title=" quality control"> quality control</a>, <a href="https://publications.waset.org/abstracts/search?q=biopharmaceutical%20manufacturing" title=" biopharmaceutical manufacturing"> biopharmaceutical manufacturing</a> </p> <a href="https://publications.waset.org/abstracts/171669/an-enhanced-approach-in-validating-analytical-methods-using-tolerance-based-design-of-experiments-doe" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/171669.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">80</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6904</span> Pharmaceutical Innovation in Jordan: KAP Analysis</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Abdel%20Qader%20Al%20Bawab">Abdel Qader Al Bawab</a>, <a href="https://publications.waset.org/abstracts/search?q=Mohannad%20Odeh"> Mohannad Odeh</a>, <a href="https://publications.waset.org/abstracts/search?q=Rami%20Amer"> Rami Amer</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Recently, there has been an increasing interest in innovative business development. Nevertheless, in the pharmacy practice field, there seems to be a gap in perceptions, attitudes, and knowledge about innovation between practicing pharmacists and academia. This study explores this gap and aspects of pharmaceutical innovation in Jordan, comparing pharmacists and last-year pharmacy students. A validated (r2 = 0.74) and reliable (Pearson’s r = 0.88) online questionnaire was designed to assess and compare knowledge, attitude, and perceptions about pharmaceutical innovation. A total of 397 participants (215 pharmacy students and 182 pharmaceutical professionals) responded. Compared with 50% of the pharmacists, only 32.1% of the students claimed that they knew the differences between pharmaceutical innovation, discovery, invention, and entrepreneurship [x2 (2) = 14.238, p = 0.001; Cramer’s V = 0.189]. Pharmacists demonstrated a higher level of trust in the innovative website design for their institution compared with students (25.3% vs. 16.3%, p < 0.001, Cramer’s V = 0.327). However, 60% of the students did not know the innovative design standards for websites, while the corresponding percentage was 37% for the pharmacists (p < 0.001; Cramer’s V = 0.327). The majority of the students were interested in pharmaceutical innovation (81.9%). Unfortunately, 76.3% never studied innovation in their pharmacy curricula. Similarly, most pharmacists (76.4%) considered adopting innovation, but only 30% had a concrete plan. For the field where pharmacists aim to innovate in the next 5 years, new pharmaceutical services were the dominant field (34.6%). Despite a positive attitude and perception, pharmacists and pharmacy students expressed poor knowledge about innovation. Policies to enhance awareness about innovation and professional educational tools should be implemented. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=pharmacy" title="pharmacy">pharmacy</a>, <a href="https://publications.waset.org/abstracts/search?q=innovation" title=" innovation"> innovation</a>, <a href="https://publications.waset.org/abstracts/search?q=knowledge" title=" knowledge"> knowledge</a>, <a href="https://publications.waset.org/abstracts/search?q=attitude" title=" attitude"> attitude</a>, <a href="https://publications.waset.org/abstracts/search?q=practice" title=" practice"> practice</a> </p> <a href="https://publications.waset.org/abstracts/158983/pharmaceutical-innovation-in-jordan-kap-analysis" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/158983.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">87</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6903</span> Synthesis and Characterization of Chitosan Microparticles for Scaffold Structure and Bioprinting</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=J.%20E.%20Mendes">J. E. Mendes</a>, <a href="https://publications.waset.org/abstracts/search?q=T.%20T.%20de%20Barros"> T. T. de Barros</a>, <a href="https://publications.waset.org/abstracts/search?q=O.%20B.%20G.%20de%20Assis"> O. B. G. de Assis</a>, <a href="https://publications.waset.org/abstracts/search?q=J.%20D.%20C.%20Pessoa"> J. D. C. Pessoa</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Chitosan, a natural polysaccharide of β-1,4-linked glucosamine residues, is a biopolymer obtained primarily from the exoskeletons of crustaceans. Interest in polymeric materials increases year by year. Chitosan is one of the most plentiful biomaterials, with a wide range of pharmaceutical, biomedical, industrial and agricultural applications. Chitosan nanoparticles were synthesized via the ionotropic gelation of chitosan with sodium tripolyphosphate (TPP). Two concentrations of chitosan microparticles (0.1 and 0.2%) were synthesized. In this study, it was possible to synthesize and characterize microparticles of chitosan biomaterial and this will be used for future applications in cell anchorage for 3D bioprinting. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=chitosan%20microparticles" title="chitosan microparticles">chitosan microparticles</a>, <a href="https://publications.waset.org/abstracts/search?q=biomaterial" title=" biomaterial"> biomaterial</a>, <a href="https://publications.waset.org/abstracts/search?q=scaffold" title=" scaffold"> scaffold</a>, <a href="https://publications.waset.org/abstracts/search?q=bioprinting" title=" bioprinting"> bioprinting</a> </p> <a href="https://publications.waset.org/abstracts/14524/synthesis-and-characterization-of-chitosan-microparticles-for-scaffold-structure-and-bioprinting" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/14524.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">322</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6902</span> Legal Regulation and Critical Analysis for an Effectively Treatment of Pharmaceutical Waste </h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Merita%20Dauti">Merita Dauti</a>, <a href="https://publications.waset.org/abstracts/search?q=Edita%20Alili-Idrizi"> Edita Alili-Idrizi</a>, <a href="https://publications.waset.org/abstracts/search?q=Sihana%20Ahmeti%20%E2%80%93Lika"> Sihana Ahmeti –Lika</a>, <a href="https://publications.waset.org/abstracts/search?q=Ledjan%20Malaj"> Ledjan Malaj </a> </p> <p class="card-text"><strong>Abstract:</strong></p> The extermination and proper disposal of pharmaceutical wastes from expired and unused medications remains a disputable issue due to their specific nature and characteristics. Even though the hazards from these wastes are already well known in terms of environment and human health, people still treat them as usual wastes. At a national level, in many countries the management of pharmaceutical and medical wastes has been one of the main objectives in order to protect people’s health and the environment. Even though many legal regulations exist in this respect, there has not been a single law that would clearly explain the procedures of returning medicines, ways of selection, treatment and extermination of pharmaceutical wastes. This paper aims at analyzing the practices of pharmaceutical waste management and treatment in some European countries as well as a review of the legislation and official guidelines in managing these kinds of wastes and protecting the environment and human health. A suitable treatment and management of expired medications and other similar wastes would be in the interest of public health in the first place, as well as in the interest of healthcare institutions and other bodies engaged in environment protection. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20waste" title="pharmaceutical waste">pharmaceutical waste</a>, <a href="https://publications.waset.org/abstracts/search?q=legal%20regulation" title=" legal regulation"> legal regulation</a>, <a href="https://publications.waset.org/abstracts/search?q=proper%20disposal" title=" proper disposal"> proper disposal</a>, <a href="https://publications.waset.org/abstracts/search?q=environment%20pollution" title=" environment pollution"> environment pollution</a> </p> <a href="https://publications.waset.org/abstracts/10453/legal-regulation-and-critical-analysis-for-an-effectively-treatment-of-pharmaceutical-waste" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/10453.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">333</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6901</span> Customers' Prescription of Foreign versus Local Brands in the Pharmaceutical Industry of Peshawar, Pakistan</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Saira%20Tajdar">Saira Tajdar</a>, <a href="https://publications.waset.org/abstracts/search?q=Sajad%20Ahmad"> Sajad Ahmad</a> </p> <p class="card-text"><strong>Abstract:</strong></p> The pharmaceutical market of Pakistan showed a mixed trend since 1947. In these six decades various local and foreign pharmaceutical companies entered the market with their highly researched based formulas and brands for various diseases. It also created a very competitive market between local and foreign companies and brands. But this intense competition does not clear the picture that whether the customers (Doctors) are preferring/prescribing foreign or local brands more frequently. Previous research has been done in various markets for different brands that whether the customers in that industry prefer foreign or local brands. However, the pharmaceutical industry in this regard has been ignored by the researchers. Generally people don't know that for prescription brands of medicines what the preferences of customers (Doctors) are. Therefore, this study is conducted in two departments of Pharmaceutical industry by selecting the top recommended formulas in those departments that for those formulas whether the customers (Doctors) are prescribing either foreign brands or local brands. Secondary data has been collected from previous studies on the country of origin (COO), ethnocentrism and factors influencing brands preferences from authentic sources. Primary data was also collected through 100 self administered questionnaires from top five hospitals of Peshawar. The results of the study were analyzed through SPSS which shows that in some categories of pharmaceutical products the COO is very important but not for all. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=customer%20prescription" title="customer prescription">customer prescription</a>, <a href="https://publications.waset.org/abstracts/search?q=country%20of%20origin" title=" country of origin"> country of origin</a>, <a href="https://publications.waset.org/abstracts/search?q=empirical%20study" title=" empirical study"> empirical study</a>, <a href="https://publications.waset.org/abstracts/search?q=foreign%20versus%20local%20brands" title=" foreign versus local brands"> foreign versus local brands</a>, <a href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20industry" title=" pharmaceutical industry"> pharmaceutical industry</a>, <a href="https://publications.waset.org/abstracts/search?q=Pakistan" title=" Pakistan"> Pakistan</a> </p> <a href="https://publications.waset.org/abstracts/21995/customers-prescription-of-foreign-versus-local-brands-in-the-pharmaceutical-industry-of-peshawar-pakistan" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/21995.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">394</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6900</span> A Spectrophotometric Method for the Determination of Folic Acid - A Vitamin B9 in Pharmaceutical Dosage Samples</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Chand%20Pasha">Chand Pasha</a>, <a href="https://publications.waset.org/abstracts/search?q=Yasser%20Turki%20Alharbi"> Yasser Turki Alharbi</a>, <a href="https://publications.waset.org/abstracts/search?q=Krasamira%20Stancheva"> Krasamira Stancheva</a> </p> <p class="card-text"><strong>Abstract:</strong></p> A simple spectrophotometric method for the determination of folic acid in pharmaceutical dosage samples was developed. The method is based on the diazotization reaction of thiourea with sodium nitrite in acidic medium yields diazonium compounds, which is then coupled with folic acid in basic medium yields yellow coloured azo dyes. Beer’s Lamberts law is observed in the range 0.5 – 16.2 μgmL-1 at a maximum wavelength of 416nm. The molar absorbtivity, sandells sensitivity, linear regression equation and detection limit and quantitation limit were found to be 5.695×104 L mol-1cm-1, 7.752×10-3 g cm-2, y= 0.092x - 0.018, 0.687 g mL-1 and 2.083 g mL-1. This method successfully determined Folate in Pharmaceutical formulations. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=folic%20acid%20determination" title="folic acid determination">folic acid determination</a>, <a href="https://publications.waset.org/abstracts/search?q=spectrophotometry" title=" spectrophotometry"> spectrophotometry</a>, <a href="https://publications.waset.org/abstracts/search?q=diazotization" title=" diazotization"> diazotization</a>, <a href="https://publications.waset.org/abstracts/search?q=thiourea" title=" thiourea"> thiourea</a>, <a href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20dosage%20samples" title=" pharmaceutical dosage samples"> pharmaceutical dosage samples</a> </p> <a href="https://publications.waset.org/abstracts/179739/a-spectrophotometric-method-for-the-determination-of-folic-acid-a-vitamin-b9-in-pharmaceutical-dosage-samples" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/179739.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">76</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6899</span> The Selectivities of Pharmaceutical Spending Containment: Social Profit, Incentivization Games and State Power</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Ben%20Main%20Piotr%20Ozieranski">Ben Main Piotr Ozieranski</a> </p> <p class="card-text"><strong>Abstract:</strong></p> State government spending on pharmaceuticals stands at 1 trillion USD globally, promoting criticism of the pharmaceutical industry's monetization of drug efficacy, product cost overvaluation, and health injustice. This paper elucidates the mechanisms behind a state-institutional response to this problem through the sociological lens of the strategic relational approach to state power. To do so, 30 expert interviews, legal and policy documents are drawn on to explain how state elites in New Zealand have successfully contested a 30-year “pharmaceutical spending containment policy”. Proceeding from Jessop's notion of strategic “selectivity”, encompassing analyses of the enabling features of state actors' ability to harness state structures, a theoretical explanation is advanced. First, a strategic context is described that consists of dynamics around pharmaceutical dealmaking between the state bureaucracy, pharmaceutical pricing strategies (and their effects), and the industry. Centrally, the pricing strategy of "bundling" -deals for packages of drugs that combine older and newer patented products- reflect how state managers have instigated an “incentivization game” that is played by state and industry actors, including HTA professionals, over pharmaceutical products (both current and in development). Second, a protective context is described that is comprised of successive legislative-judicial responses to the strategic context and characterized by the regulation and the societalisation of commercial law. Third, within the policy, the achievement of increased pharmaceutical coverage (pharmaceutical “mix”) alongside contained spending is conceptualized as a state defence of a "social profit". As such, in contrast to scholarly expectations that political and economic cultures of neo-liberalism drive pharmaceutical policy-making processes, New Zealand's state elites' approach is shown to be antipathetic to neo-liberals within an overall capitalist economy. The paper contributes an analysis of state pricing strategies and how they are embedded in state regulatory structures. Additionally, through an analysis of the interconnections of state power and pharmaceutical value Abrahams's neo-liberal corporate bias model for pharmaceutical policy analysis is problematised. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20governance" title="pharmaceutical governance">pharmaceutical governance</a>, <a href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20bureaucracy" title=" pharmaceutical bureaucracy"> pharmaceutical bureaucracy</a>, <a href="https://publications.waset.org/abstracts/search?q=pricing%20strategies" title=" pricing strategies"> pricing strategies</a>, <a href="https://publications.waset.org/abstracts/search?q=state%20power" title=" state power"> state power</a>, <a href="https://publications.waset.org/abstracts/search?q=value%20theory" title=" value theory"> value theory</a> </p> <a href="https://publications.waset.org/abstracts/166815/the-selectivities-of-pharmaceutical-spending-containment-social-profit-incentivization-games-and-state-power" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/166815.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">69</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6898</span> The Role of Stakeholders in the Development of Sustainable Supply Chain Policy Framework in the Upstream Pharmaceutical Industry in Ghana</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Gifty%20Kumadey">Gifty Kumadey</a>, <a href="https://publications.waset.org/abstracts/search?q=Albert%20Tchey%20Agbenyegah"> Albert Tchey Agbenyegah</a> </p> <p class="card-text"><strong>Abstract:</strong></p> This study explores the role of stakeholders in developing a sustainable supply chain policy framework in Ghana's pharmaceutical industry. It employs a qualitative research design to analyze policy documents, academic articles, and reports, shedding light on stakeholder involvement. The findings highlight the contributions of government agencies, regulatory bodies, pharmaceutical companies, suppliers, and civil society organizations. Key policies such as green procurement, waste management, and recycling initiatives are identified. However, challenges such as limited transparency, supplier engagement, and regulatory complexity impede implementation. The study recommends strengthening collaboration and promoting transparency to overcome these challenges. The findings provide valuable insights for policymakers, industry stakeholders, and researchers seeking to advance sustainable supply chain practices in Ghana's pharmaceutical industry. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=stakeholders" title="stakeholders">stakeholders</a>, <a href="https://publications.waset.org/abstracts/search?q=sustainable%20supply%20chain" title=" sustainable supply chain"> sustainable supply chain</a>, <a href="https://publications.waset.org/abstracts/search?q=policy%20framework" title=" policy framework"> policy framework</a>, <a href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20industry" title=" pharmaceutical industry"> pharmaceutical industry</a> </p> <a href="https://publications.waset.org/abstracts/168124/the-role-of-stakeholders-in-the-development-of-sustainable-supply-chain-policy-framework-in-the-upstream-pharmaceutical-industry-in-ghana" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/168124.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">93</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6897</span> High-Speed Electrical Drives and Applications: A Review</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Vaishnavi%20Patil">Vaishnavi Patil</a>, <a href="https://publications.waset.org/abstracts/search?q=K.%20M.%20Kurundkar"> K. M. Kurundkar</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Electrical Drives play a vital role in industry development and applications. Drives have an inevitable part in the needs of various fields such as industry, commercial, and domestic applications. The development of material technology, Power Electronics devices, and accompanying applications led to the focus of industry and researchers on high-speed electrical drives. Numerous articles charted the applications of electrical machines and various converters for high-speed applications. The choice depends on the application under study. This paper goals to highlight high-speed applications, main challenges, and some applications of electrical drives in the field. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=high-speed" title="high-speed">high-speed</a>, <a href="https://publications.waset.org/abstracts/search?q=electrical%20machines" title=" electrical machines"> electrical machines</a>, <a href="https://publications.waset.org/abstracts/search?q=drives" title=" drives"> drives</a>, <a href="https://publications.waset.org/abstracts/search?q=applications" title=" applications"> applications</a> </p> <a href="https://publications.waset.org/abstracts/182583/high-speed-electrical-drives-and-applications-a-review" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/182583.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">68</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6896</span> Potentiometric Determination of Moxifloxacin in Some Pharmaceutical Formulation Using PVC Membrane Sensors</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=M.%20M.%20Hefnawy">M. M. Hefnawy</a>, <a href="https://publications.waset.org/abstracts/search?q=A.%20M.%20A.%20Homoda"> A. M. A. Homoda</a>, <a href="https://publications.waset.org/abstracts/search?q=M.%20A.%20Abounassif"> M. A. Abounassif</a>, <a href="https://publications.waset.org/abstracts/search?q=A.%20M.%20Alanazia"> A. M. Alanazia</a>, <a href="https://publications.waset.org/abstracts/search?q=A.%20Al-Majed"> A. Al-Majed</a>, <a href="https://publications.waset.org/abstracts/search?q=Gamal%20A.%20E.%20Mostafa"> Gamal A. E. Mostafa</a> </p> <p class="card-text"><strong>Abstract:</strong></p> PVC membrane sensors using different approach e.g. ion-pair, ionophore, and Schiff-base has been used as testing membrane sensor. Analytical applications of membrane sensors for direct measurement of variety of different ions in complex biological and environmental sample are reported. The most important step of such PVC membrane sensor is the sensing active material. The potentiometric sensors have some outstanding advantages including simple design, operation, wide linear dynamic range, relative fast response time, and rotational selectivity. The analytical applications of these techniques to pharmaceutical compounds in dosage forms are also discussed. The construction and electrochemical response characteristics of Poly (vinyl chloride) membrane sensors for moxifloxacin HCl (MOX) are described. The sensing membranes incorporate ion association complexes of moxifloxacin cation and sodium tetraphenyl borate (NaTPB) (sensor 1), phosphomolybdic acid (PMA) (sensor 2) or phosphotungstic acid (PTA) (sensor 3) as electroactive materials. The sensors display a fast, stable and near-Nernstian response over a relative wide moxifloxacin concentration range (1 ×10-2-4.0×10-6, 1 × 10-2-5.0×10-6, 1 × 10-2-5.0×10-6 M), with detection limits of 3×10-6, 4×10-6 and 4.0×10-6 M for sensor 1, 2 and 3, respectively over a pH range of 6.0-9.0. The sensors show good discrimination of moxifloxacin from several inorganic and organic compounds. The direct determination of 400 µg/ml of moxifloxacin show an average recovery of 98.5, 99.1 and 98.6 % and a mean relative standard deviation of 1.8, 1.6 and 1.8% for sensors 1, 2, and 3 respectively. The proposed sensors have been applied for direct determination of moxifloxacin in some pharmaceutical preparations. The results obtained by determination of moxifloxacin in tablets using the proposed sensors are comparable favorably with those obtained using the US Pharmacopeia method. The sensors have been used as indicator electrodes for potentiometric titration of moxifloxacin. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=potentiometry" title="potentiometry">potentiometry</a>, <a href="https://publications.waset.org/abstracts/search?q=PVC" title=" PVC"> PVC</a>, <a href="https://publications.waset.org/abstracts/search?q=membrane%20sensors" title=" membrane sensors"> membrane sensors</a>, <a href="https://publications.waset.org/abstracts/search?q=ion-pair" title=" ion-pair"> ion-pair</a>, <a href="https://publications.waset.org/abstracts/search?q=ionophore" title=" ionophore"> ionophore</a>, <a href="https://publications.waset.org/abstracts/search?q=schiff-base" title=" schiff-base"> schiff-base</a>, <a href="https://publications.waset.org/abstracts/search?q=moxifloxacin%20HCl" title=" moxifloxacin HCl"> moxifloxacin HCl</a>, <a href="https://publications.waset.org/abstracts/search?q=sodium%20tetraphenyl%20borate" title=" sodium tetraphenyl borate"> sodium tetraphenyl borate</a>, <a href="https://publications.waset.org/abstracts/search?q=phosphomolybdic%20acid" title=" phosphomolybdic acid"> phosphomolybdic acid</a>, <a href="https://publications.waset.org/abstracts/search?q=phosphotungstic%20acid" title=" phosphotungstic acid"> phosphotungstic acid</a> </p> <a href="https://publications.waset.org/abstracts/20132/potentiometric-determination-of-moxifloxacin-in-some-pharmaceutical-formulation-using-pvc-membrane-sensors" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/20132.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">439</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6895</span> Cellulose Containing Metal Organic Frameworks in Environmental Applications</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Hossam%20El-Sayed%20Emam">Hossam El-Sayed Emam</a> </p> <p class="card-text"><strong>Abstract:</strong></p> As an essential issue for life, water while it’s important for all living organisms. However, the world is dangerously facing the serious problem for the deficiency of the sources of drinking water. Within the aquatic systems, there are various gases, microbes, and other toxic ingredients (chemical compounds and heavy metals) occurred owing to the draining of agricultural and industrial wastewater, resulting in water pollution. On the other hand, fuel (gaseous, liquid, or in solid phase) is one of the extensively consumable energy sources, and owing to its origin from fossil, it contains some sulfur-, nitrogen- and oxygen-based compounds that cause serious problems (toxicity, catalyst poisoning, corrosion, and gum formation andcarcinogenic effects), to be ascribed as undesirable pollutants.MOFs as porous coordinating polymers are superiorly exploited in the adsorption and separationof contaminants for wastewater treatment and fuel purification. The inclusion of highly adsorbent materials like MOFs to be immobilized within cellulosic materialscould be investigated as a new challenge for the separation of contaminants with high efficiency and opportunity for recyclability. Therefore, the current approach ascribes the exploitation of different MOFsimmobilized within cellulose (powder, films, and fabrics)for applications in environmental. Herein, using cellulose containing MOFs in dye removal (degradation and adsorption), pharmaceutical intermediates removal, and fuel purification were summarized. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=cellulose" title="cellulose">cellulose</a>, <a href="https://publications.waset.org/abstracts/search?q=MOFs" title=" MOFs"> MOFs</a>, <a href="https://publications.waset.org/abstracts/search?q=dye%20removal" title=" dye removal"> dye removal</a>, <a href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20intermediates" title=" pharmaceutical intermediates"> pharmaceutical intermediates</a>, <a href="https://publications.waset.org/abstracts/search?q=fuel%20purification" title=" fuel purification"> fuel purification</a> </p> <a href="https://publications.waset.org/abstracts/149635/cellulose-containing-metal-organic-frameworks-in-environmental-applications" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/149635.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">154</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6894</span> European Drug Serialization: Securing the Pharmaceutical Drug Supply Chain from Counterfeiters</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Vikram%20Chowdhary">Vikram Chowdhary</a>, <a href="https://publications.waset.org/abstracts/search?q=Marek%20Vins"> Marek Vins</a> </p> <p class="card-text"><strong>Abstract:</strong></p> The profitability of the pharmaceutical drug business has attracted considerable interest, but it also faces significant challenges. Counterfeiters take advantage of the industry's vulnerabilities, which are further exacerbated by the globalization of the market, online trading, and complex supply chains. Governments and organizations worldwide are dedicated to creating a secure environment that ensures a consistent and genuine supply of pharmaceutical products. In 2019, the European authorities implemented regulation EU 2016/161 to strengthen traceability and transparency throughout the entire drug supply chain. This regulation requires the addition of enhanced security features, such as serializing items to the saleable unit level or individual packs. Despite these efforts, the incidents of pharmaceutical counterfeiting continue to rise globally, with regulated territories being particularly affected. This paper examines the effectiveness of the drug serialization system implemented by European authorities. By conducting a systematic literature review, we assess the implementation of drug serialization and explore the potential benefits of integrating emerging digital technologies, such as RFID and Blockchain, to improve traceability and management. The objective is to fortify pharmaceutical supply chains against counterfeiters and manipulators and ensure their security. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=blockchain" title="blockchain">blockchain</a>, <a href="https://publications.waset.org/abstracts/search?q=counterfeit%20drugs" title=" counterfeit drugs"> counterfeit drugs</a>, <a href="https://publications.waset.org/abstracts/search?q=EU%20drug%20serialization" title=" EU drug serialization"> EU drug serialization</a>, <a href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20industry" title=" pharmaceutical industry"> pharmaceutical industry</a>, <a href="https://publications.waset.org/abstracts/search?q=RFID" title=" RFID"> RFID</a> </p> <a href="https://publications.waset.org/abstracts/167784/european-drug-serialization-securing-the-pharmaceutical-drug-supply-chain-from-counterfeiters" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/167784.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">110</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6893</span> Photo-Degradation of a Pharmaceutical Product in the Presence of a Catalyst Supported on a Silicoaluminophosphate Solid</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=I.%20Ben%20Kaddour">I. Ben Kaddour</a>, <a href="https://publications.waset.org/abstracts/search?q=S.%20Larbaoui"> S. Larbaoui</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Since their first synthesis in 1984, silicoaluminophosphates have proven their effectiveness as a good adsorbent and catalyst in several environmental and energy applications. In this work, the photocatalytic reaction of the photo-degradation of a pharmaceutical product in water was carried out in the presence of a series of materials based on titanium oxide, anatase phase, supported on the microporous framework of the SAPO4-5 at different levels, under ultraviolet light. These photo-catalysts were characterized by different physicochemical analysis methods in order to determine their structural, textural, and morphological properties, such as X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), microscopy scanning electronics (SEM), nitrogen adsorption measurements, UV-visible diffuse reflectance spectroscopy (UV-Vis-DRS). In this study, liquid chromatography coupled with spectroscopy of mass (LC-MS) was used to determine the nature of the intermediate products formed during the photocatalytic degradation of DCF. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=photocatalysis" title="photocatalysis">photocatalysis</a>, <a href="https://publications.waset.org/abstracts/search?q=titanium%20dioxide" title=" titanium dioxide"> titanium dioxide</a>, <a href="https://publications.waset.org/abstracts/search?q=SAPO-5" title=" SAPO-5"> SAPO-5</a>, <a href="https://publications.waset.org/abstracts/search?q=diclofenac" title=" diclofenac"> diclofenac</a> </p> <a href="https://publications.waset.org/abstracts/175667/photo-degradation-of-a-pharmaceutical-product-in-the-presence-of-a-catalyst-supported-on-a-silicoaluminophosphate-solid" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/175667.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">68</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6892</span> Resolving Problems Experienced by Involving Patients in the Development of Pharmaceutical Products at Post-Launch Stage of Pharmaceutical Product Development</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Clara%20T.%20Fatoye">Clara T. Fatoye</a>, <a href="https://publications.waset.org/abstracts/search?q=April%20Betts"> April Betts</a>, <a href="https://publications.waset.org/abstracts/search?q=Abayomi%20Odeyemi"> Abayomi Odeyemi</a>, <a href="https://publications.waset.org/abstracts/search?q=Francis%20A.%20Fatoye"> Francis A. Fatoye</a>, <a href="https://publications.waset.org/abstracts/search?q=Isaac%20O.%20Odeyemi"> Isaac O. Odeyemi</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Background: The post-launch stage is the last stage in the development of a pharmaceutical product. It is important to involve patients in the development of pharmaceutical products at the post-launch stage, as patients are the end-users of pharmaceutical products. It is expected that involving them might ensure an effective working relationship among the various stakeholders. However, involving patients in the development of pharmaceutical products comes with its problems. Hence, this study examined how to resolve problems experienced by involving patients in the developments of pharmaceutical products’ at post-launch consisting of Positioning of pharmaceutical products (POPP), detailing of pharmaceutical products (DOPP) and reimbursement and Formulary Submission (R&FS). Methods: A questionnaire was used for the present study. It was administered at the ISPOR Glasgow 2017 to 104 participants, all of which were professionals from Market access (MA) and health economics and outcomes research (HEOR) backgrounds. They were asked how the issues experienced by patients can be resolved. Participants responded under six domains as follows: communication, cost, effectiveness, external factors, Quality of life (QoL) and safety. Thematic analysis was carried out to identify strategies to resolve issues experienced by patients at the post-launch stage. Results: Three (3) factors cut across at POPP, DOPP, and R&FS that is (external factors, communication and QoL). The first resolution method was an external factor that is, the relationship with stakeholders and policymakers. Communication was also identified as a resolution method that can help to resolve problems experienced by patients at the post-launch stage. The third method was QoL as perceived by the patients based on professionals’ opinions. Other strategies that could be used to resolve problems experienced were the effectiveness of pharmaceutical products at the DOPP level and cost at R&FS. Conclusion: The study showed that focusing on external factors, communication, and patients’ QoL are methods for resolving issues experienced by involving patients at the post-launch stage of pharmaceutical product development. Hence, effective working relationships between patients, policymakers and stakeholders may help to resolve problems experienced at the post-launch stage. Healthcare policymakers are to be aware of these findings as they may help them to put appropriate strategies in place to enhance the involvement of patients in pharmaceutical product development at the post-launch stage, thereby improving the health outcomes of the patients. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=patients" title="patients">patients</a>, <a href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20products" title=" pharmaceutical products"> pharmaceutical products</a>, <a href="https://publications.waset.org/abstracts/search?q=post-launch%20stage" title=" post-launch stage"> post-launch stage</a>, <a href="https://publications.waset.org/abstracts/search?q=quality%20of%20life" title=" quality of life"> quality of life</a>, <a href="https://publications.waset.org/abstracts/search?q=QoL" title=" QoL"> QoL</a> </p> <a href="https://publications.waset.org/abstracts/112270/resolving-problems-experienced-by-involving-patients-in-the-development-of-pharmaceutical-products-at-post-launch-stage-of-pharmaceutical-product-development" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/112270.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">130</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6891</span> Impact of Task Technology Fit on User Effectiveness, Efficiency and Creativity in Iranian Pharmaceutical Oraganizations</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Milad%20Keshvardoost">Milad Keshvardoost</a>, <a href="https://publications.waset.org/abstracts/search?q=Amir%20Khanlari"> Amir Khanlari</a>, <a href="https://publications.waset.org/abstracts/search?q=Nader%20Khalesi"> Nader Khalesi</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Background: Any firm in the pharmaceutical industry requires efficient and effective management information systems (MIS) to support managerial functions. Purpose: The aim of this study is to investigate the impact of Task-Technology Fit on user effectiveness, efficiency, and creativity in Iranian pharmaceutical companies. Methodology: 345 reliable and validate questionnaires were distributed among selected samples, through the cluster method, to Information system users of eight leading Iranian pharmaceutical companies, based on the likert scale. The proposed model of the article is based on a model with Task technology fit, on user performance with the definition of efficiency, effectiveness, and creativity through mediation effects of perceived usefulness and ease of use. Results: This study confirmed that TTF with definitions of adequacy and compatibility has positive impacts on user performance Conclusion: We concluded that pharmaceutical users of IS, utilizing a system with a precise and intense observation of users' demands, may make facilitation for them to design an exclusive IS framework. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=information%20systems" title="information systems">information systems</a>, <a href="https://publications.waset.org/abstracts/search?q=user%20performance" title=" user performance"> user performance</a>, <a href="https://publications.waset.org/abstracts/search?q=pharmaceuticals" title=" pharmaceuticals"> pharmaceuticals</a>, <a href="https://publications.waset.org/abstracts/search?q=task%20technology%20fit" title=" task technology fit"> task technology fit</a> </p> <a href="https://publications.waset.org/abstracts/149801/impact-of-task-technology-fit-on-user-effectiveness-efficiency-and-creativity-in-iranian-pharmaceutical-oraganizations" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/149801.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">170</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6890</span> Production of Biosurfactant by Pseudomonas luteola on a Reject from the Production of Anti-scorpion Serum</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Radia%20Chemlal">Radia Chemlal</a>, <a href="https://publications.waset.org/abstracts/search?q=Youcef%20Hamidi"> Youcef Hamidi</a>, <a href="https://publications.waset.org/abstracts/search?q=Nabil%20Mameri"> Nabil Mameri</a> </p> <p class="card-text"><strong>Abstract:</strong></p> This study deals with the production of biosurfactant by the Pseudomonas luteola strain on three different culture media (semi-synthetic medium M1, whey, and pharmaceutical reject) in the presence of gasoil. The monitoring of bacterial growth by measuring the optical density at 600 nm by spectrophotometer and the surface tension clearly showed the ability of Pseudomonas luteola to produce biosurfactants at various conditions of the culture medium. The biosurfactant produced in the pharmaceutical reject medium generated a decrease in the surface tension with a percentage of 19.4% greater than the percentage obtained when using whey which is 7.0%. The pharmaceutical rejection is diluted at various percentages ranging from 5% to 100% in order to study the effect of the concentration on the biosurfactant production. The best result inducing the great reduction of the surface tension value is obtained at the dilution of 30% with the pharmaceutical reject. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=biosurfactant" title="biosurfactant">biosurfactant</a>, <a href="https://publications.waset.org/abstracts/search?q=pseudomonas%20luteola" title=" pseudomonas luteola"> pseudomonas luteola</a>, <a href="https://publications.waset.org/abstracts/search?q=whey" title=" whey"> whey</a>, <a href="https://publications.waset.org/abstracts/search?q=antiscorpionic%20serum" title=" antiscorpionic serum"> antiscorpionic serum</a>, <a href="https://publications.waset.org/abstracts/search?q=gas%20oil" title=" gas oil"> gas oil</a> </p> <a href="https://publications.waset.org/abstracts/159333/production-of-biosurfactant-by-pseudomonas-luteola-on-a-reject-from-the-production-of-anti-scorpion-serum" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/159333.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">102</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6889</span> Occurrence of Pharmaceutical Compounds in an Urban Lake</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=J.%20D.%20Villanueva">J. D. Villanueva</a>, <a href="https://publications.waset.org/abstracts/search?q=N.%20Peyraube"> N. Peyraube</a>, <a href="https://publications.waset.org/abstracts/search?q=I.%20Allan"> I. Allan</a>, <a href="https://publications.waset.org/abstracts/search?q=G.%20D.%20Salvosa"> G. D. Salvosa</a>, <a href="https://publications.waset.org/abstracts/search?q=M.%20Reid"> M. Reid</a>, <a href="https://publications.waset.org/abstracts/search?q=C.%20Harman"> C. Harman</a>, <a href="https://publications.waset.org/abstracts/search?q=K.%20D.%20Salvosa"> K. D. Salvosa</a>, <a href="https://publications.waset.org/abstracts/search?q=J.%20M.%20V.%20Castro"> J. M. V. Castro</a>, <a href="https://publications.waset.org/abstracts/search?q=M.%20V.%20O.%20Espaldon"> M. V. O. Espaldon</a>, <a href="https://publications.waset.org/abstracts/search?q=J.%20B.%20Sevilla-Nastor"> J. B. Sevilla-Nastor</a>, <a href="https://publications.waset.org/abstracts/search?q=P.%20Le%20Coustumer"> P. Le Coustumer</a> </p> <p class="card-text"><strong>Abstract:</strong></p> The main objectives of this research are to (1) assess the occurrence of the pharmaceutical compounds and (2) present the environmental challenges posed by the existence of these pharmaceutical compounds in the surface water. These pharmaceuticals were measured in Napindan Lake, Philippines. This lake is not only a major tributary of the Pasig River (an estuary) and Laguna Lake (freshwater). It also joins these two important surface waters of the National Capital Region. Pharmaceutical compounds such as Atenolol, Carbamazepine, and two other over the counter medicines: Cetirizine, and Ibuprofen were measured in Napindan Lake. Atenolol is a beta blocker that helps in lowering hypertensions. Carbamazepine is an anticonvulsant used as treatment for epilepsy and neuropathic pain. Cetirizine is an antihistamine that can relieve allergies. Ibuprofen is a non-steroidal anti-inflammatory drug normally used to relieve pains. Three different climatological conditions with corresponding hydro physico chemical characteristics were considered. First, was during a dry season with a simultaneous dredging. Second was during a transition period from dry to wet season. Finally, the third was during a continuous wet event. Based from the results of the study, most of these pharmaceuticals can be found in Napindan Lake. This is a proof that these pharmaceutical compounds are being released to a natural surface water. Even though climatological conditions were different, concentrations of these pharmaceuticals can still be detected. This implies that there is an incessant supply of these pharmaceutical compounds in Napindan Lake. Chronic exposure to these compounds even at low concentrations can lead to possible environmental and health risks. Given this information and since consistent occurrence of these compounds can be expected, the main challenge, at present, is on how to control the sources of these pharmaceutical compounds. Primarily, there is a need to manage the disposal of the pharmaceutical compounds. Yet, the main question is how to? This study would like to present the challenges and institutional roles in helping manage the pharmaceutical disposals in a developing country like the Philippines. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=atenolol" title="atenolol">atenolol</a>, <a href="https://publications.waset.org/abstracts/search?q=carbamazepine" title=" carbamazepine"> carbamazepine</a>, <a href="https://publications.waset.org/abstracts/search?q=cetirizine" title=" cetirizine"> cetirizine</a>, <a href="https://publications.waset.org/abstracts/search?q=ibuprofen" title=" ibuprofen"> ibuprofen</a>, <a href="https://publications.waset.org/abstracts/search?q=institutional%20roles" title=" institutional roles"> institutional roles</a>, <a href="https://publications.waset.org/abstracts/search?q=Napindan%20lake" title=" Napindan lake"> Napindan lake</a>, <a href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20compound%20disposal%20management" title=" pharmaceutical compound disposal management"> pharmaceutical compound disposal management</a>, <a href="https://publications.waset.org/abstracts/search?q=surface%20water" title=" surface water"> surface water</a>, <a href="https://publications.waset.org/abstracts/search?q=urban%20lake" title=" urban lake"> urban lake</a> </p> <a href="https://publications.waset.org/abstracts/122704/occurrence-of-pharmaceutical-compounds-in-an-urban-lake" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/122704.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">162</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">6888</span> Study the Effect of Sensitization on the Microstructure and Mechanical Properties of Gas Tungsten Arc Welded AISI 304 Stainless Steel Joints</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Viranshu%20Kumar">Viranshu Kumar</a>, <a href="https://publications.waset.org/abstracts/search?q=Hitesh%20Arora"> Hitesh Arora</a>, <a href="https://publications.waset.org/abstracts/search?q=Pradeep%20Joshi"> Pradeep Joshi</a> </p> <p class="card-text"><strong>Abstract:</strong></p> SS 304 is Austenitic stainless steel with Chromium and Nickel as basic constituents. It has excellent corrosion resistance properties and very good weldability. Austenitic stainless steels have superior mechanical properties at high temperatures and are used extensively in a range of applications. SS 304L has wide applications in various industries viz. Nuclear, Pharmaceutical, marine, chemical etc. due to its excellent applications and ease of joining this material has become very popular for fabrication as well as weld surfacing. Austenitic stainless steels have a tendency to form chromium depleted zones at the grain boundaries during welding and heat treatment, where chromium combines with available carbon in the vicinity of the grain boundaries, to produce an area depleted in chromium, and thus becomes susceptible to intergranular corrosion. This phenomenon is known as sensitization. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=sensitization" title="sensitization">sensitization</a>, <a href="https://publications.waset.org/abstracts/search?q=SS%20304" title=" SS 304"> SS 304</a>, <a href="https://publications.waset.org/abstracts/search?q=GTAW" title=" GTAW"> GTAW</a>, <a href="https://publications.waset.org/abstracts/search?q=mechanical%20properties" title=" mechanical properties"> mechanical properties</a>, <a href="https://publications.waset.org/abstracts/search?q=carbideprecipitationHAZ" title=" carbideprecipitationHAZ"> carbideprecipitationHAZ</a>, <a href="https://publications.waset.org/abstracts/search?q=microstructure" title=" microstructure"> microstructure</a>, <a href="https://publications.waset.org/abstracts/search?q=micro%20hardness" title=" micro hardness"> micro hardness</a>, <a href="https://publications.waset.org/abstracts/search?q=tensile%20strength" title=" tensile strength"> tensile strength</a> </p> <a href="https://publications.waset.org/abstracts/21758/study-the-effect-of-sensitization-on-the-microstructure-and-mechanical-properties-of-gas-tungsten-arc-welded-aisi-304-stainless-steel-joints" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/21758.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">398</span> </span> </div> </div> <ul class="pagination"> <li class="page-item disabled"><span class="page-link">&lsaquo;</span></li> <li class="page-item active"><span class="page-link">1</span></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20applications&page=2">2</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20applications&page=3">3</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20applications&page=4">4</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20applications&page=5">5</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20applications&page=6">6</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20applications&page=7">7</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20applications&page=8">8</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20applications&page=9">9</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20applications&page=10">10</a></li> <li class="page-item disabled"><span class="page-link">...</span></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20applications&page=230">230</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20applications&page=231">231</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=pharmaceutical%20applications&page=2" rel="next">&rsaquo;</a></li> </ul> </div> </main> <footer> <div id="infolinks" class="pt-3 pb-2"> <div class="container"> <div style="background-color:#f5f5f5;" class="p-3"> <div class="row"> <div class="col-md-2"> <ul class="list-unstyled"> About <li><a href="https://waset.org/page/support">About Us</a></li> <li><a href="https://waset.org/page/support#legal-information">Legal</a></li> <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/WASET-16th-foundational-anniversary.pdf">WASET celebrates its 16th foundational anniversary</a></li> </ul> </div> <div class="col-md-2"> <ul class="list-unstyled"> Account <li><a href="https://waset.org/profile">My Account</a></li> </ul> </div> <div class="col-md-2"> <ul class="list-unstyled"> Explore <li><a href="https://waset.org/disciplines">Disciplines</a></li> <li><a href="https://waset.org/conferences">Conferences</a></li> <li><a href="https://waset.org/conference-programs">Conference Program</a></li> <li><a href="https://waset.org/committees">Committees</a></li> <li><a href="https://publications.waset.org">Publications</a></li> </ul> </div> <div class="col-md-2"> <ul class="list-unstyled"> Research <li><a href="https://publications.waset.org/abstracts">Abstracts</a></li> <li><a href="https://publications.waset.org">Periodicals</a></li> <li><a href="https://publications.waset.org/archive">Archive</a></li> </ul> </div> <div class="col-md-2"> <ul class="list-unstyled"> Open Science <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/Open-Science-Philosophy.pdf">Open Science Philosophy</a></li> <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/Open-Science-Award.pdf">Open Science Award</a></li> <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/Open-Society-Open-Science-and-Open-Innovation.pdf">Open Innovation</a></li> <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/Postdoctoral-Fellowship-Award.pdf">Postdoctoral Fellowship Award</a></li> <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/Scholarly-Research-Review.pdf">Scholarly Research Review</a></li> </ul> </div> <div class="col-md-2"> <ul class="list-unstyled"> Support <li><a href="https://waset.org/page/support">Support</a></li> <li><a href="https://waset.org/profile/messages/create">Contact Us</a></li> <li><a href="https://waset.org/profile/messages/create">Report Abuse</a></li> </ul> </div> </div> </div> </div> </div> <div class="container text-center"> <hr style="margin-top:0;margin-bottom:.3rem;"> <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank" class="text-muted small">Creative Commons Attribution 4.0 International License</a> <div id="copy" class="mt-2">© 2024 World Academy of Science, Engineering and Technology</div> </div> </footer> <a href="javascript:" id="return-to-top"><i class="fas fa-arrow-up"></i></a> <div class="modal" id="modal-template"> <div class="modal-dialog"> <div class="modal-content"> <div class="row m-0 mt-1"> <div class="col-md-12"> <button type="button" class="close" data-dismiss="modal" aria-label="Close"><span aria-hidden="true">×</span></button> </div> </div> <div class="modal-body"></div> </div> </div> </div> <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script src="https://cdn.waset.org/static/plugins/jquery-3.3.1.min.js"></script> <script src="https://cdn.waset.org/static/plugins/bootstrap-4.2.1/js/bootstrap.bundle.min.js"></script> <script src="https://cdn.waset.org/static/js/site.js?v=150220211556"></script> <script> jQuery(document).ready(function() { /*jQuery.get("https://publications.waset.org/xhr/user-menu", function (response) { jQuery('#mainNavMenu').append(response); });*/ jQuery.get({ url: "https://publications.waset.org/xhr/user-menu", cache: false }).then(function(response){ jQuery('#mainNavMenu').append(response); }); }); </script> </body> </html>